Close
Nordic 9Nordic 9

Jens Mogensen (investor - Angel Investor)

Sweden
See something wrong or missing? Let us know
Offices:Stockholm
Average round investment:1.82M USD
Average number per year:1.0
Distribution: 2024 (1)2023 (1)2020 (1)
Portfolio companies: Sweden Thioredoxin SystemsSweden Harvest MoonSweden Fairlo
Mostly invests in: Sweden Sweden (3) Biotech (1)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Jens Mogensen

Name Criteria
Norway Åge Westbø
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Financial Services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Albert & Anna Göranssons Minne
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Filip Weintraub
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Financial Services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Greg Dingizian
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Manufacturing, Financial Services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Hans Frykman
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Johan Markman
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Mikael Lönn
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Rolf Bjerndell
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Stassi Anastassov
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Pharma, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Thomas Feldthus
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Pharma, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top